IPEX Syndrome, FOXP3 and Cancer
Journal Title: Journal of Syndromes - Year 2014, Vol 1, Issue 1
Abstract
In this review, we introduce the IPEX syndrome and its relationship with germline mutations of the FOXP3 gene. We then describe the multiple functional roles of FOXP3 in regulatory T cells and epithelial cells as well as in IPEX syndrome and tumor progression. Potential mechanisms of FOXP3 inactivation and transcriptional regulation are discussed with recent advances. Finally, we point out current issues and a potential FOXP3-mediated therapeutic strategy as well as the reactivation of FOXP3 in patients with IPEX syndrome and cancer.
Authors and Affiliations
Lizhong Wang
Evaluation of the SERM Ormeloxifene in the Treatment of Uterine Fibroid in the Reproductive Age Group
Background: The search for the ideal drug for medical treatment of fibroids is on. SERMs appear to be novel agents for hormonal manipulations. Ormeloxifene with biweekly dosing and minimum side effects needs evaluation f...
Cowden Syndrome: Case Report with Late Diagnosis
The authors present a case of Cowden syndrome, which was only diagnosed at the age of 45. It is very important to make an early diagnosis, periodical clinical and lab exams in these patients in order to prevent the patie...
RNA Dysfunction and RNA binding Proteins in the Syndrome of ALS/FTD
RNA dysfunction and abnormal intracellular aggregates comprise a key characteristic in most neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The discoveries wit...
IPEX Syndrome, FOXP3 and Cancer
In this review, we introduce the IPEX syndrome and its relationship with germline mutations of the FOXP3 gene. We then describe the multiple functional roles of FOXP3 in regulatory T cells and epithelial cells as well as...
Different Clinical Courses with Severe Postpartum Coagulopathy in Two Cases Showing the Same Histological Findings those Local Amniotic Fluid Emboli
We report two cases of postpartum intractable bleeding with coagulopathy. Case 1: A 34-year-old low-risk woman at 39 weeks of gestation was admitted to our hospital. After an uneventful vaginal delivery, placenta sepa...